drugset / Trial / NCT01893359

Safety and Efficacy of Corneal Collagen Cross-linking Following LASIK for Treatment of Hyperopia and Hyperopic Astigmatism

NCT01893359

Phase 1/2 Terminated 2 enrolled Glaukos Corporation
RandomizedParallel-groupSingle-blindTreatment

Summary

The objectives of this study are to evaluate the safety and efficacy, with regards to regression of refractive outcome, as measured by manifest refraction spherical equivalent (MRSE), of two treatment regimens for hyperopic and hyperopic astigmatic subjects: LASIK followed by cross-linking performed with the KXL System and Photrexa ZD™ (Riboflavin Ophthalmic Solution), as compared to LASIK alone.

Timeline

Start
2013-08
Primary completion
2015-02
Completion
2016-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Riboflavin Other / unclassified Topical

Indications